In the IG primary yesterday, two issues were priced totaling US$2.8bn, lifting weekly IG issuance to US$15.90bn and September volume to US$135.70bn, according to IFR data. The average book order for ...

Kajeet and Avery Telehealth announced a strategic partnership. The FDA has approved Apple’s sleep apnea detection feature.

Ascendis Pharma A/S (ASND) said that it has priced its underwritten public offering of 2 million American Depositary Shares or 'ADSs' ...

A/S (Nasdaq: ASND) today announced the pricing of its underwritten public offering of 2,000,000 American Depositary Shares ...

Ascendis Pharma A/S (ASND) said that it has commenced an underwritten public offering of $300 million of American Depositary Shares ...

A/S (Nasdaq: ASND) today announced that it has commenced an underwritten public offering of $300,000,000 of American ...

Ascendis Pharma (Nasdaq: ASND) has announced positive top-line data from the pivotal Phase II ApproaCH trial of TransCon CNP ...

Check the time stamp on this data. Updated AI-Generated Signals for Ascendis Pharma A/s (ASND) available here: ASND.

The combination of belrestotug and dostarlimab significantly improved response rates in patients with previously untreated ...

Summary study results show Ascendis’ drug for achondroplasia could be competitive to BioMarin's Voxzogo, which is the foundation of the latter company's growth plans.

The defense and aerospace industry is thriving as the war continues. Boeing (BA) and AeroVironment (AVAV) are the exceptions. On Monday, AVAV stock lost 9.68% after the U.S. Government Accountability ...

Ascendis Pharma has emerged as a potential threat to BioMarin’s Voxzogo, reporting phase 3 growth disorder data that exceeded ...